Dibutyl phthalate |CAS 84-74-2|DC Chemicals

Cas No.:	84-74-2
Chemical Name:	Dibutyl phthalate
Synonyms:	Dibutyl phthalate;1,2-benzenedicarboxylic acid dibutyl ester;ARALDITE RESIN;Benzenedicarboxylic acid dibutyl ester;DBP;DBP(R);DIBUTYL 1,2-BENZENEDICARBOXYLATE;DI-N-BUTYL PHTHALATE;DL-N-BUTYL PHTHALATE;N-BUTYL PHTHALATE;O-BENZENEDICARBOXYLIC ACID DIBUTYL ESTER;PHTHALIC ACID, BIS-BUTYL ESTER;PHTHALIC ACID DIBUTYL ESTER;PHTHALIC ACID DI-N-BUTYL ESTER;ai-3-00283;benzene-1,2-dicarboxylicaciddibutylester;Benzene-o-dicarboxylic acid, di-n-butyl ester;Bufa;1,2-Benzenedicarboxylic acid;Dibutyl phthalate solution;Dibutyl Phthalate-13C6,d4;Di-n-butyl phthalate (DBP);Di-n-butyl phthalate solution;Phthalic acid butyl ester;1,2-dibutyl 1,2-benzenedicarboxylate;1000μg;2,6-di-t-butyl-4-methyl-phenol;butyl dibutylphosphinate;butyl phthalate;Butylester of dibutylphosphinic acid;dibutyl benzene-1,2-dicarboxylate;dibutyl-phosphinic acid butyl ester;Dibutylphosphinsaeure-butylester;dibutylphosphonic acid butyl ester;Phosphinic acid,dibutyl-,butyl ester;Celluflex DPB;Elaol;Genoplast B;Palatinol C;Polycizer DBP;Unimoll DB;DIBUTYLPHTHALATE;Dibutyl-o-phthalate;Staflex DBP;Hexaplas M/B;Ergoplast FDB;Kodaflex DBP;DBP (ester);N-Butylphthalate;Ersoplast FDA;Phthalate, di-n-butyl;Uniflex DBP;Hatcol DBP;Dibutyl o-phthalate;RC Plasticizer DBP;1,2-Benzenedicarboxylic ac;Palatinol DBP;dibutyl phthalate; DBP;Phthalic acid di-n-butyl ester;Butyl phthalate;DIBUTYL PHTHALATE (II);KBio2_002532;DIBUTYL PHTHALATE [USP-RS];Uniplex 150;NA9095;CHEBI:34687;S5377;KBioGR_001267;NCGC00254882-01;di-n-butyl phthalate (dbp);HSDB 922;Dibutyl-1,2-benzenedicarboxylate;BDBM50371946;NSC 6370;2286E5R2KE;MLS002177802;KBio2_007668;Di(n-butyl) 1,2-benzenedicarboxylate;Ruifeng vp 201;ortho-Dibutyl phthalate;CS-0013564;CHEMBL272485;Bisoflex DBP;Ftalato di n-butanolo;Dibutyl phthalate, >=99%;Dibutyl phthalate, United States Pharmacopeia (USP) Reference Standard;Phthalic acid dibutyl ester;Dibutyl phthalate, PESTANAL(R), analytical standard;NCGC00090769-08;SpecPlus_000628;BRN 1914064;Dibutyl phthalate [NF];DB13716;NCGC00090769-01;Di(1-butyl) phthalate;Dibutyl-1,2-benzene-dicarboxylate;SMR000777923;Dibutyl phthalate, SAJ special grade, >=98.0%;KBio3_002047;Benzol-1,2-dicarbonsauredibutylester;Q415612;Witcizer 300;RAPIDCELLtrade markP;HMS3041E18;Phthalic acid, dibutyl ester;Dibutyl 1, 2-benzenedicarboxylate;NCGC00259278-01;Dibutyl Phthalate, Pharmaceutical Secondary Standard; Certified Reference Material;Benzene-o-dicarboxylic acid di-n-butyl ester;Dibutyl 1,2-benzene-dicarboxylate;Dibutylftalat;Ersoplast FDA.;dibutyl phthalate;Dibutyl phthalate, LR, >=98%;Di-n-butyl phthalate;Phthalic acid, bis-butyl ester;Di n Butyl Phthalate;RCRA waste number U069;SR-05000001549-3;DIBUTYL PHTHALATE [MART.];DIBUTYL PHTHALATE (SEE ALSO PEROXISOME PROJECT (DIBUTYL PHTHALATE));Phthalate, Dibutyl;di-n-butyl phthalate (DBuP);Sicol 140;Dibutyl phthalate, Selectophore(TM);o-Benzenedicarboxylic acid, dibutyl ester;D...
SMILES:	O=C(C1C(C(OCCCC)=O)=CC=CC=1)OCCCC
Formula:	C₁₆H₂₂O₄
M.Wt:	278.343485355377
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

In Vitro Dibutyl phthalate (0.001 µg/mL-1000 µg/mL) is detrimental to follicle growth and viability and results in significant dysregulation of cell cycle and apoptosis gene expression in a dose-specific manner. But MBP does not play a role in Dibutyl phthalate toxicity in follicles exposed in vitro. In Vivo Dibutyl phthalate (200, 400, or 600 mg/kg/day) induces decrease mice weight, impairment of spermatogenesis, reduces serum follicle stimulating hormone and testosterone level, alters testicular LDH, increases LPO, and decreases the levels of enzymatic antioxidants with histopathological anomalies. Dibutyl phthalate (6.25, 12.5, 25, 50, 100 and 200 mg/kg) could cause some neurobehavioral adverse effects in mice.

Cat. No.	Product name	Field of application
DC31079	Abarelix	Abarelix is a synthetic decapeptide and antagonist of naturally occurring gonadotropin-releasing hormone (GnRH). Abarelix directly and competitively binds to and blocks the gonadotropin releasing hormone receptor in the anterior pituitary gland, thereby inhibiting the secretion and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH). In males, the inhibition of LH secretion prevents the release of testosterone. As a result, this may relieve symptoms associated with prostate hypertrophy or prostate cancer, since testosterone is required to sustain prostate growth.
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC79856	EVT0185	EVT0185 is an orally active ATP citrate lyase (ACLY) inhibitor. EVT0185 is converted to a CoA thioester in the liver by SLC27A2 and interacts with the CoA-binding site of ACLY. EVT0185-CoA inhibits ACLY activity with an IC50 of 2.5 μM. EVT0185 can phenocopy the immune and antitumour effects of genetic ACLY deletion. EVT0185 can increase tumour-infiltrating B cells and chemokine CXCL13 levels. EVT0185 can be used for the research of cancer, such as hepatocellular carcinoma (HCC).
DC79609	NCGC00685960	NCGC00685960 is a Nicotinamide N-methyltransferase (NNMT) inhibitor with an IC50 < 10  nM. NCGC00685960 has potent antitumor activity. NCGC00685960 increases H3K27 trimethylation levels in ovarian cancer cells and inhibits α-SMA expression in NNMT-expressing ovarian fibroblasts. NCGC00685960 reduces 1-MNA levels, reverses SAM and H3K27 hypomethylation and significantly impairs collagen contractility in cancer-associated fibroblasts (CAFs). NCGC00685960 can be used for cancers research.
DC79112	Simepdekinra	Simepdekinra (Compound 221) is a IL-17A modulator with IC50s ≤10  nM and 10-100 nM for IL-17A/A HEK-Blue and IL-17A/F HEK-Blue cells. Simepdekinra can be used for inflammatory diseases such as psoriasis, ankylosing spondylitis and psoriatic arthritis research.
DC78751	RSL3-NH2	RSL3-NH2 is a GPX4 inhibitor and Ferroptosis inducer. RSL3-NH2 can be used as a cytotoxic payload for synthesis of antibody-drug conjugates (ADCs).
DC77831	Vicadrostat	Vicadrostat (compound 29 A) is a potent and selective inhibitor of aldosterone synthase(CYP11B2) with an IC50 of 16 nM. It exhibits potential in renal disease, diabetic nephropathy, cardiovascular diseases and fibrotic disorder research.
DC77813	Zeltociclib	Zeltociclib is a cyclin-dependent kinase inhibitor with antitumor effects.
DC77784	UNC10013	UNC10013 is a SETDB1 allosteric modulator that forms a covalent bond with Cys385 in the 3TD domain, exhibiting negative allosteric regulatory activity. It has a kinact/KI value of 1.0 × 106 M-1*s-1. UNC10013 effectively disrupts SETDB1-mediated Akt methylation and holds potential value for research in cancer and neurodegenerative diseases.
DC77740	T0080	T0080 is a FPR-1 antagonist. T0080 reduces the cell apoptosis, inhibits ROS production and pro-inflammatory cytokines (TNF-α and IL-1β) from plaque macrophages, which attenuates atherosclerotic progression in ApoE−/− mice.